Matthew Taylor
Stock Analyst at Jefferies
(4.39)
# 1,220
Out of 4,455 analysts
659
Total ratings
54.7%
Success rate
7%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Rated: Buy | $100 → $67 | $44.23 | +51.48% | 51 | Jun 24, 2026 | |
| SYK Stryker | Maintained: Buy | $465 → $455 | $332.71 | +36.76% | 35 | Jun 18, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $102 | $90.78 | +12.36% | 68 | May 27, 2026 | |
| MDT Medtronic | Rated: Hold | $95 | $80.98 | +17.31% | 40 | Apr 24, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $135 | $94.12 | +43.43% | 42 | Apr 17, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $105 → $110 | $109.80 | +0.18% | 13 | Mar 18, 2026 | |
| PODD Insulet | Reiterated: Buy | $400 | $158.25 | +152.76% | 30 | Feb 19, 2026 | |
| GEHC GE HealthCare Technologies | Maintained: Buy | $105 | $65.76 | +59.67% | 10 | Feb 18, 2026 | |
| DXCM DexCom | Reiterated: Buy | $112 | $70.14 | +59.68% | 36 | Feb 13, 2026 | |
| BAX Baxter International | Reiterated: Hold | $19 | $22.04 | -13.79% | 34 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $86.25 | +33.33% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $16.24 | +195.57% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $12 | $10.29 | +16.62% | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $22.79 | -16.63% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 → $110 | $93.10 | +18.15% | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $80 | $83.43 | -4.11% | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $63 | $88.38 | -28.72% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $17.33 | +61.57% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $2.94 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $404.70 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $305 → $255 | $155.92 | n/a | 29 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $129.86 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.00 → $34.50 | $15.33 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $14.63 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $5.72 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $164 → $245 | $200.29 | n/a | 15 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $18.76 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 | $35.95 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $4.24 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 364.00 → CHF 255.00 | $194.40 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $316.63 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5.5 | $8.89 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $181.46 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €49.00 | $23.89 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $34.22 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.5 → $1 | $7.20 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $13.40 | n/a | 2 | Jul 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.5 | $0.000001 | n/a | 2 | May 12, 2016 |
Boston Scientific
Jun 24, 2026
Rated: Buy
Price Target: $100 → $67
Current: $44.23
Upside: +51.48%
Stryker
Jun 18, 2026
Maintained: Buy
Price Target: $465 → $455
Current: $332.71
Upside: +36.76%
Edwards Lifesciences
May 27, 2026
Maintained: Buy
Price Target: $102
Current: $90.78
Upside: +12.36%
Medtronic
Apr 24, 2026
Rated: Hold
Price Target: $95
Current: $80.98
Upside: +17.31%
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $135
Current: $94.12
Upside: +43.43%
Lantheus Holdings
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $109.80
Upside: +0.18%
Insulet
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $158.25
Upside: +152.76%
GE HealthCare Technologies
Feb 18, 2026
Maintained: Buy
Price Target: $105
Current: $65.76
Upside: +59.67%
DexCom
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $70.14
Upside: +59.68%
Baxter International
Feb 12, 2026
Reiterated: Hold
Price Target: $19
Current: $22.04
Upside: -13.79%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $86.25
Upside: +33.33%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $16.24
Upside: +195.57%
Oct 3, 2025
Maintained: Hold
Price Target: $15 → $12
Current: $10.29
Upside: +16.62%
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $22.79
Upside: -16.63%
Aug 7, 2025
Maintained: Hold
Price Target: $130 → $110
Current: $93.10
Upside: +18.15%
Aug 7, 2025
Maintained: Buy
Price Target: $79 → $80
Current: $83.43
Upside: -4.11%
Aug 7, 2025
Maintained: Buy
Price Target: $61 → $63
Current: $88.38
Upside: -28.72%
Aug 5, 2025
Maintained: Buy
Price Target: $28
Current: $17.33
Upside: +61.57%
Jun 4, 2025
Maintained: Buy
Price Target: $18
Current: $2.94
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: n/a
Current: $404.70
Upside: n/a
May 1, 2025
Maintained: Buy
Price Target: $305 → $255
Current: $155.92
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $129.86
Upside: n/a
Apr 28, 2025
Maintained: Buy
Price Target: $33.00 → $34.50
Current: $15.33
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $14.63
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $5.72
Upside: n/a
Oct 25, 2024
Maintained: Hold
Price Target: $164 → $245
Current: $200.29
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $18.76
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $105
Current: $35.95
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $4.24
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: $194.40
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $316.63
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $7 → $5.5
Current: $8.89
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $181.46
Upside: n/a
Jan 25, 2022
Maintained: Buy
Price Target: €49.00
Current: $23.89
Upside: n/a
Dec 6, 2019
Maintained: Hold
Price Target: n/a
Current: $34.22
Upside: n/a
Mar 8, 2018
Maintained: Sell
Price Target: $1.5 → $1
Current: $7.20
Upside: n/a
Jul 19, 2017
Maintained: Hold
Price Target: $17 → $16
Current: $13.40
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $5 → $2.5
Current: $0.000001
Upside: n/a